Energy and Commodities OTC Clearing and Execution under Dodd-Frank Regulation roundtable

Challenges continuously arise regarding energy and commodities OTC clearing, and changes in regulations. This roundtable offers the knowledge, experience and opinions of our elite speakers on some of the key issues the industry currently faces including:

 Energy and Commodities OTC Clearing and Execution under Dodd-Frank Regulation roundtable
  • What are the requirements for organizations to standardize swaps to be traded under Dodd-Frank?
  • Where are we at regarding preparations made across the industry for the changes in rules on clearing and execution process? 
  • Risk management: what are the characteristics clients will be looking at when selecting clearing houses? 
  • What are the qualities clients will be considering when choosing a dealer or FCM?

Click here to register to view the Energy and Commodities OTC Clearing and Execution under Dodd-Frank Regulation roundtable

In association with CME Group, KPMG and SuperDerivatives

The industry expert speakers are:

  • CME Group: Thomas LaSala, Managing Director, Chief Regulatory Officer and Tim Doar, Managing Director, Risk Management
  • KPMG: John D’Agostino, Advisor, former hedge fund manager and Nymex VP 
  • CW&T: Gregory Mocek, former CFTC enforcer for 8 years 
  • ICAP: Patrick J. McCarty, Managing Director, Government Relations and Regulatory Affairs in the United States, former General Counsel, CFTC 
  • SuperDerivatives: Zohar Hod, VP - Head of Americas & Global Strategic Sales

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here